XML 63 R54.htm IDEA: XBRL DOCUMENT v3.23.3
STOCKHOLDERS’ EQUITY - Stock Option Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
 9 Months Ended 12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Sep. 30, 2022
Number of Shares      
Outstanding at beginning of period (in shares) 781,092    
Granted (in shares) 0 0  
Exercised (in shares) (97,802)    
Canceled (in shares) (30,871)    
Outstanding at end of period (in shares) 652,419   781,092
Weighted-Average Exercise Price (in dollars per share)      
Outstanding at beginning of period (in dollars per share) $ 7.46    
Granted (in dollars per share) 0    
Exercised (in dollars per share) 7.49    
Canceled (in dollars per share) 9.49    
Outstanding at end of period (in dollars per share) $ 7.36   $ 7.46
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]      
Vested and Expected to Vest (in shares) 652,419    
Exercisable (in shares) 643,018    
Vested and Expected to Vest, Weighted-Average Exercise Price (in dollars per share) $ 7.36    
Exercisable, Weighted-Average Exercise Price (in dollars per share) $ 7.32    
Outstanding, Weighted-Average Remaining Contractual Terms (in Years) 4 years 6 months   3 years 8 months 12 days
Vested and Expected to Vest, Weighted-Average Remaining Contractual Term (in Years) 4 years 6 months    
Exercisable, Weighted-Average Remaining Contractual Term (in Years) 4 years 6 months    
Outstanding, Aggregate Intrinsic Value $ 2,273   $ 1,512
Vested and Expected to Vest, Aggregate Intrinsic Value 2,273    
Exercisable, Aggregate Intrinsic Value $ 2,261